SCHEMBL30980698

SCHEMBL30980698

CCOC(=O)CNCCOCCOCCNC(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
TDP1 Q9NUW8 1/20 0.41
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
ADRB2 P07550 1/20 0.40
HTR1A P08908 1/20 0.40
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 2/20 0.39
CTSK P43235 1/20 0.39
TSHR P16473 1/20 0.39
IDO1 P14902 1/20 0.39
LTA4H P09960 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1061879 0.89 ACHE (0.41) MAOAMAOBTDP1CA12CA1
SCHEMBL3361834 0.89 ACHE (0.41) MAOAMAOBTDP1CA12CA1
SCHEMBL1064998 0.89 ACHE (0.41) MAOAMAOBTDP1CA12CA1
SCHEMBL432412 0.87 MAOA (0.51) MAOAMAOBTDP1CA12CA1
SCHEMBL23499716 0.86 TDP1 (0.43) MAOAMAOBTDP1CA12CA1
SCHEMBL21070375 0.86 TDP1 (0.43) MAOAMAOBTDP1CA12CA1
SCHEMBL21070586 0.86 TDP1 (0.43) MAOAMAOBTDP1CA12CA1
SCHEMBL21070330 0.86 TDP1 (0.43) MAOAMAOBTDP1CA12CA1
SCHEMBL21657442 0.86 TDP1 (0.43) MAOAMAOBTDP1CA12CA1
SCHEMBL1747780 0.86 TDP1 (0.43) MAOAMAOBTDP1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651901-A1 CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 EP disclosed
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 EP disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 WO disclosed